Aspf7(18 kDa) and alkaline protease (33 kDa) are the 2 major antigens which are derived from Aspergillus (A.)fumigatus and have been implicated as possible virulence factors in the pathogenesis ofAspergillus-indnced diseases. Weattempted to detect fragments of genes encoding both proteins from fungus balls obtained at surgery or autopsy by polymerase chain reaction (PCR) amplification and then used PCRto test clinical samples. Frozen-stored fungus ball samples from a patient with acute myeloid leukemia complicated by Aspergillus pneumonia and from a patient with pulmonary aspergilloma were studied. Wesuccessfully amplified a 315 bp PCR product, the target sequence for Aspfl, and a 747 bp PCRproduct as a target sequence for alkaline protease (ALP) in both cases. In addition, 13 clinical samples including sputum specimens from patients with pulmonary aspergillosis were also examined. PCRanalysis for the Aspfl (ALP) gene in clinical samples showed positive results in 5/10 (6/10) patients with pulmonary aspergilloma and in 3/3 (1/ 3) patients with invasive pulmonary aspergillosis.
Introduction Aspergillus (A.)fumigatus is thought to be the most pathogenic Aspergillus species for humans. This fungus is found ubiquitously and is capable of causing a wide spectrum of humandiseases including allergic and invasive aspergillosis (1) .
Aspfl and alkaline protease (ALP) are the 2 major allergens or antigens derived from A. fumigatus and they have been implicated as possible virulence factors in the pathogenesis of Aspergillus-induced diseases (2) (3) (4) . Aspfl has been reported to be an 1 8 kDa IgE binding protein and amember of the mitogillin family of cytotoxins, which promotes colonization and infection by A. fumigatus over other Aspergillus species (2, 4) .
In contrast, ALP, which is a serine protease of the subtilisin family, has a molecular weight of 32-33 kDa (5, 6 ). This enzyme is responsible for most, if not all, detectable extracellular elastinolytic activity, and is also capble ofdestructing lung tissue and it facilitates tissue invasion by the fungus (5-7). To date, DNAsequences of both genes have already been elucidated by gene cloning (2, 3, 8) . In this study, we focused on these 2 molecules and attempted to detect fragments of genes encoding both proteins from fungus balls obtained at surgery or autopsy by polymerase chain reaction (PCR) amplification. Then, we also examined the clinical samples from patients with pulmonary aspergillosis by PCRin order to develop more sensitive methods compared to the conventional culture or immunodiagnosis.
Materials and Methods

Fungus balls
Two frozen-stored fungus ball samples derived from a patient with acute myeloid leukemia complicated by Aspergillus pneumonia and from a patient with pulmonary aspergilloma were studied (Table 1) . The diagnosis ofA.fumigatus infection was made based on the histopathological studies at autopsy or on surgically removed specimens reviewed by the pathologists. Chest radiographs of these patients are shown in Fig. 1 . Chest radiograph of patient 1 showed multiple nodular shadows in the bilateral lung fields which progressively worsened over a 2-week period until he died. Chest radiograph of patient 2 shows a small nodule located in his left lower lobe. A chest computed tomographic scan taken before left lower lobectomy revealed a thin layer of air space surrounding the nodule. Fungus balls were removed at autopsy or surgery and stored at -70°C until used. These samples were vortexed with glass beads and treated with extraction buffer containing 1 % SDSand 100 jag/ml proteinase K (Sigma, St. Louis, MO, USA) according to the method described by Tang et al (7) . Then, DNAwas PCRprimers For the detection oftheAspfl gene, weused a set of primer pairs which is predicted to generate a 3 15 bp amplified product. The PCRprimers forAspfl were as follows: The upper primer was 5' TGG-ACA-TGC-ATC-AAC-CAA 3' (ASP1) which is a modification of that used by Reddy et al (9) , and the lower primer was 5' GTC-AAA-CTT-ATA-GTC-GTG3' (ASP2) for the amplification of the 3 15 bp gene fragment. For the detection of the ALPgene, we used a single primer pair which is predicted to generate a 747 bp amplified product (10) . The upper primer was 5T AGC-ACC-GAC-TAC-ATC-TAC 3' (ALP1) and the lower primer was 5' GAG-ATG-GTG-TTG-GTG-GC 3! (ALP2). 1 00 pmol of both primers, and 2.5 U TaKaRaTaq DNApolymerase (Takara Shuzo, Tokyo) with denaturation at 94°C for 1 minute, annealing at 45°C for 1 minute, and extension at 72°C for 3 minutes. For amplification of the ALPgene, the thermal cycling conditions used were 42 cycles at 94°C for 30 seconds, 63°C for 45 seconds, and 72°C for 2 minutes. As a precaution to prevent template contamination, preparation of DNAsamples , preparation of reaction solutions, and PCRamplification were performed in different rooms using a safety cabinet or clean bench and aerosol resistant pipette tips (Molecular Bio-products, Inc, San Diego, CA, USA).
Gel electrophoresis and Southern blot hybridization PCR products (10 \xl) were electrophoresed in 2% agarose, stained with ethidium bromide (0.5 jug/ml), and visualized with UVlight. The DNAwas transferred from the gels by Southern transfer onto nylon membranes (Hybond N, AmershamInternational, Buckinghamshire, UK). The membranes were hybridized with 5' end-digoxigenin-labeled internal oligonucleotide in the earlier part of this study. However, digoxigenin-labeled PCRprobes were alternatively used in the later study, because the probe synthesis is more simple. Briefly, a digoxigenin labeling mixture (Boehringer-Mannheim, GmBH,Germany) was used in place of dNTPin the PCRreaction amplifying the respective target gene from A.fumigatus DNAunder the same thermal cycling conditions, as for the synthesis of digoxigenin incorporated PCRprobe (1 1).
Subsequently , non-radioisotopic chemiluminescence detection was performed using CSPDá" (Tropix, Bed ford, MA Clinical samples Further, 12 sputum samples from patients with pulmonary aspergilloma (n=10), a patient with invasive pulmonary aspergillosis (n=l), and a patient with eosinophilic pneumonia (n=l) were tested. In addition, a bronchial aspirate from a patient with culture proven invasive pulmonary aspergillosis (n= 1 ), bronchoalveolar lavage fluid (BALF) from a patient with surgically confirmed invasive pulmonary aspergillosis (n= l), and pleural effusion from a patient with probable invasive aspergillosis (n=l) were also examined. Pulmonary aspergilloma was diagnosed from the characteristic radiological appearance of the presence of a radio-opaque mass in the lung cavity with an air-crescent sign (13, 14) . Two patients with invasive pulmonary aspergillosis were pathologically confirmed by autopsy (15, 1.6), as was another case with invasive pulmonary aspergillosis, whounderwent left upper surgical lobectomy for life-threatening hemoptysis (16). A patient with probable invasive pulmonary aspergillosis was assumed based on the co-existence of invasion to the pleural space and the parietal pericardium, which had never been implicated by the involvement of the underlying disease (16). Apatient with eosinophilic pneumonia was initially thought to have allergic bronchopulmonary aspergillosis, but was found to have normal levels of serum IgE and negative specific IgE values for A. fumigatus afterwards (17). All of the clinical samples were added to an equal volumeof extraction buffer. After incubation at 65°C for 3 hours, the mixture wasextracted according to a modification of the method described by Wake field et al (18).
Results
PCR detection of Asp fI and ALP genes in fungus bails
Agarose gel electrophoresis and Southern blot hybridizations are shown in parallel (Fig. 2) . The 315 bp amplified gene fragment of AspfI ( Fig. 2A ) and the 747 bp amplified gene fragment ofALP were both generated by PCR (Fig. 2B ). These results demonstrated that both fungus balls resulted from an A. fumigatus infection as shownbelow. Specificity of the PCR detection ofA. fumigatus DNA Specificity studies were conducted as follows. DNA(100 ng) from other members of the Aspergillus species, Candida albicans, and humanleucocytes were used as targets. Ethidium bromide-stained gels and Southern blot hybridizations are shown in Fig. 3 . Noted that a 315 bp gene fragment was amplified from A. fumigatus DNAwhile the 3 15 bp product was amplified from neither fungal strain sample nor human DNA (Fig. 3A) . After Southern blot hybridization, a 3 15 bp amplified product could be detected solely from A. fumigatus DNA, representing the detection of the Aspfl gene as shown in Fig. 3A .
In contrast, the use ofPCRfor the detection of the ALPgene, amplification products could be detected both from A.fumigatus and A. flavus DNAsafter ethidium bromide and Southern blot analysis. In the ethidium bromide-stained gel, the size of the predicted amplification product from A.fumigatus was 747 bp, and that from A.flavus was 690 bp. In Southern blot analysis, the hybridization signal was intense forA.fumigatus, but it was faint for A. flavus, probably because the digoxigenin-incorporated PCR amplified fragments ofA. fumigatus (141 bp) were used to probe the Southern blots (Fig. 3B ).
Sensitivity of PCRdetection of A. fumigatus DNA Sensitivity studies were carried out by using serially diluted DNAextracted fromA.fumigatus as the target. As the result, 10 pg ofA.fumigatus DNAcould be detected by PCR for the Asp fl gene after Southern blot analysis (Fig. 4A) . In contrast, 100 pg ofA.fumigatus DNAcould be detected by PCR for the ALP gene after Southern blot analysis (Fig. 4B ). Based on this study, amplification of the Aspfl gene has an advantage over that of the ALPgene in terms of sensitivity.
PCR detection of the Asp fi gene in clinical samples A set of PCRprimer pairs which is predicted to generate a 315 bp product was chosen for the PCRdetection of the Aspf I gene from clinical samples including sputum. An amplification product corresponding to the size of the fragment (3 15 bp) from A. fumigatus could be detected in 5 out of the first consecutive 12 samples (Fig. 5 ). Figure 5 . Application ofPCRfor the detection oftheAspflgene to clinical samples including sputum specimens with the ASP1and ASP2 primer pair. Amplification products corresponding to the size offragment expected from A.fumigatus (315 bp) are seen in lanes 1, 5, 6, 7, and 10. Lanes 1-4 and 6-9, sputum samples from patients with pulmonary aspergilloma; lane 5, a bronchial aspirate from patients with invasive pulmonary aspergillosis; lanes 10 and ll; sputum samples from a patient with invasive pulmonary aspergillosis and a patient with eosinophilic pneumonia, respectively; lane 12, pleural effusion from patients with probable invasive aspergillosis.
PCRdetection of the ALPgene in the clinical samples PCRwas carried out using the sameDNA samples as used for the PCR of the Asp f I gene. An amplification product corresponding to the size of a fragment (747 bp) from A. fumigatus could be detected in 6 out of the first 12 consecutive samples (Fig. 6 ).
Summaryof patient characteristics and PCRresults
The PCRresults, culture data on A. fumigatus, and patient profiles are summarized in Table 2 . The first consecutive sample (patient) number, from 1 to 12, coincides with the lane number as shown in Figs. 5 and 6. Three additional samples whose patient numbers were from 13 to 16 were also examined and are included in the list. PCR for the Aspfl gene revealed that 5 of 10 patients with pulmonary aspergilloma and 3 of 3 patients with invasive pulmonary aspergillosis gave positive results. In contrast, PCR for the ALPgene showed that 6 of 10 patients with pulmonary aspergilloma, and 1 of 3 patients with invasive pulmonary aspergillosis gave positive results. Another sample of pleural effusion from a patient with probable invasive aspergillosis was only PCR positive for the ALP gene. The culture data on A.
fumigatus showed that 3 of 9 patients with pulmonary aspergilloma, and 2 of 3 patients with invasive pulmonary aspergillosis gave positive results. Consequently, the overall results indicated that the positive rate for PCRanalysis of the Aspfl gene was 8/13, for the ALP gene was 7/13, and that for the culture data was 5/12, in pulmonary aspergillosis.
Discussion
To date, several PCR-based amplification methods for the detection of A. fumigatus from clinical samples have been reported (19) (20) (21) . Most methods utilize 18S ribosomal RNAas the target sequence. Therefore, someof these methodsallow detection of Penicillium species together with Aspergillus species. In contrast, 2 studies chose other molecules as target sequences. One selectedAspfl (9), and the otherALP (10), both of which are thought to be possible virulence factors in the pathogenesis of pulmonary aspergillosis. Aspfl is exclusively produced in association with germination and the fungal growth ofA.fumigatus andA. restrictus, and causes humanantibody responses in patients with various forms of pulmonary aspergillosis. In fact, the highest levels of IgG and IgE antibodies against Aspfl are found in sera from Weused PCRto examine clinical samples including sputum specimens. We analyzed respiratory secretions (sputum, bronchial aspirate, and BALF), by PCR for the Aspfl gene, and found that 5 of 10 patients with pulmonary aspergilloma and 3 of 3 patients with invasive pulmonary aspergillosis gave positive results. In contrast, PCRfor the ALPgene showed 6 of 10 patients with pulmonary aspergilloma, and 1 of 3 patients with invasive pulmonary aspergillosis gave positive results. Conversely, culture data on A.fumigatus showed that 3 of 9 patients with pulmonary aspergilloma, and 2 of 3 patients with invasive pulmonaryaspergillosis gave positive results. The overall results indicated the positive rate for PCRfor the Aspfl gene was 8/13, for theALPgene was 7/13, and for the culture data was 5/ 12, in pulmonary aspergillosis. In this sense, this study does not conclusively demonstrate the superiority of our PCRmethod.
In order to validate whether our approach is more sensitive than conventional culture, a prospective study including larger numbers of samples is clearly required. In our series, there appears to be a lower incidence of PCR positivity in patients with pulmonary aspergilloma. This may be due to the fact that aspergilloma may be caused by other membersof Aspergillus species and that there is a lower shedding rate of fungal DNA into the sputumwithout the invasive process. Because the germination of spores and fungal growth is closely associated with the active expression of the Aspfl gene, it is less likely to occur in this situation (4). We presume the respiratory secretions from invasive pulmonary aspergillosis, if obtainable, should be good materials for PCR diagnosis.
The discrepancy of the PCR results between the Aspfl and ALPgenes in some of the samples seems to be explained by the time lag of the secretion of these proteins by A.furnigatus, but this point needs to be confirmed with a larger number of samples (22) . Additionally, there is a concern that the size of the PCR product from the ALPgene is rather longer to be amplified easily from materials than that of the Aspfl gene, depending on the quality of the samples. In fact, PCRanalysis oftheALP gene showed a lower positive rate (1/3) in samples from confirmed invasive pulmonary aspergillosis in comparison with PCR analysis of the Aspfl gene (3/3). The present view is that PCR for the Asp fI gene is better than PCR for the ALP gene. However, further investigations including the selection of the more optimal target sequences for the ALPgene are required.
In conclusion, because more than 95%of the invasive pulmonary aspergillosis in humansare reported to be caused by A.fumigatus (1), the Aspfl gene in conjunction with ALP gene appears to be a promising candidate for the target of PCR diagnosis with regards to respiratory secretions, particularly in clinical settings where conventional culture results are not readily available.
